Zebra Medical Vision Ltd.

Based in Kibutz Shfayim, Israel, and founded in 2014 by co-founders Eyal Toledano and Eyal Gura, Zebra Medical Vision Ltd. (Zebra-Me) offers medical image diagnosis and provides radiologists with the tools needed for patient care. As of 2021, the company has seven US Foods and Drug Administration (FDA)-approved and ten CE-marked AI solutions for medical imaging and launched a 3D modeling solution for x-ray images that is used for pre-operative planning of orthopedic surgical operations.  In August 2021, Nanox acquired Zebra Medical Vision for USD 200 million.

The company's platform analyzes patient imaging data to identify early, previously undetected signs of common chronic diseases, allowing healthcare institutions to detect various acute conditions and offer preventative treatment pathways to improve patient care while significantly lowering associated costs. With the acquisition in August 2021, Nanox will establish a med-tech business by combining Zebra-staff, Med's revolutionary AI technology, and Cloud experience, as well as a one-of-a-kind regulatory framework.  Also, With its AI-powered solutions, Zebra-Med plans to expand its goal of diagnosing patients at scale.